Jacobs Levy Equity Management, Inc Athersys, Inc Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $112,154 - $184,724	-131,946 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.33 - $1.77 $42,609 - $56,705	-32,037 Reduced 19.54%	131,946 $175,000
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $231,216 - $318,127	163,983 New	163,983 $236,000
Q2 2020 Aug 17, 2020	SELL	$1.97 - $3.98 $57,986 - $117,151	-29,435 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.17 - $3.0 $231,058 - $592,458	-197,486 Reduced 87.03%	29,435 $88,000
Q4 2019 Feb 14, 2020	BUY	$1.16 - $1.42 $263,228 - $322,227	226,921 New	226,921 $279,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.